论文部分内容阅读
目的:探讨疏肝理脾法联合热疗及动脉灌注化疗治疗晚期胰腺癌的近期疗效。方法:我院住院治疗符合病例入选标准的65例晚期胰腺癌患者,随机分为治疗组(动脉灌注化疗加腹腔热疗、四逆散加减)31例和对照组(单纯动脉灌注化疗)34例,观察两组的近期疗效、疼痛评分、肝郁脾虚证积分、脾气虚证积分、毒副反应、体力状态评分。结果:治疗组与对照组比较,CR+PR+SD分别为85.71%,71.88%(P<0.05);疼痛控制CR+PR+MR分别为85.71%,62.5%(P<0.05);治疗组和对照组肝郁脾虚证证候积分分别为(10.81±4.09),(15.27±5.67)分,治疗组低于对照组(P<0.05)。结论:疏肝理脾中药联合热疗及局部动脉灌注化疗临床获益率高于单纯动脉灌注化疗。
Objective: To explore the short-term curative effect of Shugan and spleen combined with hyperthermia and arterial infusion chemotherapy in the treatment of advanced pancreatic cancer. Methods: A total of 65 patients with advanced pancreatic cancer were enrolled in our hospital. The patients were randomly divided into treatment group (arterial infusion chemotherapy combined with celiac hyperthermia and Siniger addition and subtraction) and control group (arterial infusion chemotherapy only). Cases were observed, the short-term efficacy of the two groups, pain scores, scores of liver depression and spleen deficiency syndrome, spleen deficiency syndrome score, toxicity, physical status score. Results: Compared with the control group, CR + PR + SD was 85.71% and 71.88% respectively in the treatment group and CR + PR + MR group (85.71% and 62.5%, P <0.05) The points of syndrome of liver depression and spleen deficiency in the control group were (10.81 ± 4.09) and (15.27 ± 5.67) points, respectively. The treatment group was lower than the control group (P <0.05). Conclusion: Shugan Li spleen Chinese medicine combined with hyperthermia and local arterial infusion chemotherapy clinical benefit rate was higher than simple arterial infusion chemotherapy.